Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), March 2025 The Doxy-PEP Decision Making Tool supports prescribing doxycycline post-exposure prophylaxis (Doxy-PEP) to gay and bisexual men and transgender women at increased risk of syphilis. Suitable patients include those with recent syphilis or other STI diagnoses, periods of increased risk, or who wish to protect...
interg Anwernekenhe National HIV Alliance; Health Equity Matters (formerly AFAO), June 2023 In these two episodes of the Indigenous podcast series, the Anwernekenhe National HIV Alliance are joined by several Brotherboys and Sistergirls to discuss the impacts of racism and access to healthcare. Listen to The impacts of racism on access to healthcare for Brotherboys (55 mins) Listen to The impacts...
Zoe Belle Gender Collective Transfemme is an Australian website designed to promote healthier relationships between trans women and cisgender men. This website has been created by the Zoe Belle Gender Collective in collaboration with a collective of Victorian-based trans women and cis men who have experience in dating or are in relationships with trans women. The content is based on the...
NDARC at UNSW , June 2021 The Understanding Lesbian, bisexual and queer women’s Experiences of Alcohol, Substance Use and Health (UnLEASH) Study explores lesbian, bisexual and queer women’s health and wellbeing and the relationship with smoking, drinking, and using drugs. We want to give voices to those in our communities that have not been heard before and we need your help! Led by...
ACON, October 28, 2020 The latest 2020 SWASH report was released on 28th October 2020 as part of a series of Mental Health month events. The SWASH survey is a comprehensive survey of important health issues relevant to lesbian, bisexual, queer and other non-heterosexual identifying women engaged with Sydney’s lesbian, gay, bisexual, transgender, intersex and queer (LGBTIQ) communities. SWASH has...
nam/aidsmap, 7 September 2020 A study in which 24 trans women and 24 trans men who were taking gender-affirming hormone therapy were directly observed to take a daily dose of the standard formulation of the HIV prevention medication PrEP found that the levels of the two PrEP drugs tenofovir and emtricitabine were similar to the levels seen in similar cis men and women, and were all above levels...